-
Health todayCancer refines
Shared genetic risk across cancers sits in specific regions, not across the genome
Across 16 cancers, genome-wide analysis identified 20 correlated cancer pairs, whereas analysis region by region identified shared genetic signals across 66 pairs.
Peer-reviewed -
Health todayCancer confirms
Cancer risk in treated HIV followed age and smoking, not immune status
Among 7507 people with HIV on antiretroviral therapy, 219 cancers occurred over a median 5.6 years, with older age and current smoking associated with risk but immune markers not.
Peer-reviewed -
Health todayCancer refines
PSA density separates later prostate cancer risk after a negative screening MRI
Among 1,685 men with a negative screening MRI, seven-year incidence of significant prostate cancer was 5.5% below a PSA density of 0.10 ng/mL2 and more than double that above it.
Peer-reviewed -
Health todayCancer refines
Familial adenomatous polyposis found by screening matches general population mortality
Relatives found by family screening to have familial adenomatous polyposis had mortality comparable to the general population (median SMR 0.66), against 11.09 for patients presenting with symptoms.
Peer-reviewed -
Health todayCancer new
A model puts daraxonrasib at $500,637 per quality-adjusted life year in pancreatic cancer
A cost-effectiveness model built from the RASolute 302 trial put daraxonrasib at $500,637 per quality-adjusted life year gained over chemotherapy, at a US price of $39,800 per 30 days.
Preprint · not peer-reviewed -
Health todayCancer refines
Cancer polygenic scores were weaker in African-ancestry than European-ancestry veterans
Across 560,287 US veterans, all 13 cancer polygenic scores were associated with their own cancer in European-ancestry participants, but only five of 13 were in African-ancestry participants.
Peer-reviewed -
Health todayCancer new
Fine particulate matter shows no association with ovarian cancer across pooled cohorts
A systematic review of 145 studies of environmental chemical exposures and gynaecologic cancers found no pooled association between PM2.5 and ovarian cancer (HR 1.02 per 5 µg/m³, 95% CI 0.91–1.13) and only a marginal one for endometrial cancer (HR 1.02, 95% CI 0.99–1.05).
Peer-reviewed -
Health todayCancer refines
Pancreatic cancer risk on GLP-1 drugs depends on the diabetes drug compared
Pancreatic cancer was less common in GLP-1 starters than in starters of four other diabetes classes, while against insulin the paper reports a lower hazard but a higher absolute risk.
Peer-reviewed -
Health todayCancer confirms
Colorectal screening from 45 still misses cancers diagnosed before that age
A review of 45 studies found detection of colorectal neoplasia rises with age under 50, but a considerable share of cases arise before 45 and outside screening eligibility.
Peer-reviewed -
Health todayCancer new
Second primary lung cancers in Sweden have risen steadily since 1980
The Swedish national cancer registry identified 853 second primary lung cancers from 1961 to 2021, arising at 3.59 times the rate at which first lung cancers arise in the population.
Peer-reviewed -
Health todayCancer confirms
Scotland's lung screening pilot drew a 23.8% response to its invitations
Inviting 2801 people with a smoking history recorded in Scottish primary care records to a lung health check produced a response rate of 23.8%, lower in more deprived areas.
Peer-reviewed -
Health todayCancer new
Oral KRAS G12D inhibitor GFH375 shrank tumours in a third of pancreatic cancers
In 74 heavily pretreated patients with KRAS G12D-mutant advanced solid tumours, the oral inhibitor GFH375 produced confirmed responses in 35.1% of pancreatic cancers and 35.7% of lung cancers.
Peer-reviewed